Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model
Open Access
Abstract
Adenovirus ocular infections are common ocular viral infections seen worldwide, for which there is no approved antiviral therapy available. Ranpirnase is a novel ribonuclease which preferentially degrades tRNA resulting in an inhibition of protein synthesis. The study goal was to determine the anti-adenoviral activity of topical formulations of ranpirnase (OKG-0301) on adenoviral replication in the Ad5/NZW rabbit ocular replication model. NZW rabbits were inoculated in both eyes with human adenovirus type 5 (HAdV5) after corneal scarification. A day later, topical therapy was initiated in both eyes with 0.03% OKG-0301, 0.003% OKG-0301, saline or 0.5% cidofovir. Eyes were cultured to determine HAdV5 eye titers over 2 weeks. OKG-0301 (0.03% and 0.003%) and 0.5% cidofovir decreased viral titers compared to saline. Furthermore, both OKG-0301 formulations and 0.5% cidofovir shortened the duration of the HAdV5 infection compared to saline. Both 0.03% OKG-0301 and 0.003% OKG-0301 demonstrated increased antiviral activity compared to saline in the Ad5/NZW rabbit ocular replication model. The antiviral activity of the OKG-0301 groups was similar to that of the positive antiviral control, 0.5% cidofovir. Ranpirnase (OKG-0301) may be a potential candidate for a topical antiviral for adenoviral eye infections. Further clinical development is warranted.Keywords
Funding Information
- Okogen, Pty Ltd., NIH Core Grant for Vision Research (EY08098)
- The Eye & Ear Foundation of Pittsburgh
- University of Pittsburgh Department of Ophthalmology from Research to Prevent Blindness
This publication has 24 references indexed in Scilit:
- Analysis of Human Adenovirus Type 19 Associated with Epidemic Keratoconjunctivitis and its Reclassification as Adenovirus Type 64Investigative Ophthalmology & Visual Science, 2012
- Treatment of Epidemic Keratoconjunctivitis with 2% Povidone–Iodine: A Pilot StudyJournal of Ocular Pharmacology and Therapeutics, 2011
- Clinical and Antiviral Efficacy of an Ophthalmic Formulation of Dexamethasone Povidone-Iodine in a Rabbit Model of Adenoviral KeratoconjunctivitisInvestigative Ophthalmology & Visual Science, 2011
- The In Vitro and In Vivo Evaluation of ddC as a Topical Antiviral for Ocular Adenovirus InfectionsInvestigative Ophthalmology & Visual Science, 2009
- Efficacy of Topical Immunoglobulins against Experimental Adenoviral Ocular InfectionInvestigative Ophthalmology & Visual Science, 2007
- N-Chlorotaurine Is an Effective Antiviral Agent against Adenovirus In Vitro and in the Ad5/NZW Rabbit Ocular ModelInvestigative Ophthalmology & Visual Science, 2006
- Entry into Cells and Selective Degradation of tRNAs by a Cytotoxic Member of the RNase A FamilyJournal of Biological Chemistry, 2002
- Inhibition of HIV-1 Production and Selective Degradation of Viral RNA by an Amphibian RibonucleaseJournal of Biological Chemistry, 1996
- Activity of Ganciclovir Against Human Adenovirus Type-5 Infection in Cell Culture and Cotton Rat EyesCornea, 1994
- Ribonuclease Treatment of Tick-Borne EncephalitisArchives of Neurology, 1976